Gamida Cell Ltd.

203 articles about Gamida Cell Ltd.

• Gamida Cell Ltd. Announces the Successful Transplantation of the First Patient in the Company's Phase I/II Study of NiCord® in a Single Cord Configuration

  9/9/2013

• Gamida Cell Ltd. Reports FDA Recommending Further Study of StemEx®

  7/1/2013

• Gamida Cell Ltd.'s NiCord® Demonstrates Successful Engraftment in Patients With Hematological Malignancies in Phase I/II Study

  2/15/2013

• Gamida Cell Ltd. Reports Success in Blood Cancer Trial

  2/4/2013

• Gamida Cell Ltd. Completes Enrollment for Phase I/II Study of Second Pipeline Product NiCord® for Hematological Malignancies

  9/19/2012

• Gamida Cell Ltd. Raises $10 Million to Progress Phase III-Stage Hematologic Cancer Cell Therapy

  5/15/2012

• Gamida Cell Ltd.-Teva Pharmaceutical Industries Limited Joint Venture Concludes Enrollment for the Phase III Study of StemEx®, a Cord Blood Stem Cell Product, for Leukemia and Lymphoma

  2/13/2012

• The Gamida Cell Ltd.-Teva Pharmaceutical Industries Limited Joint Venture Receives Green Light From the Data Monitoring Committee to Continue the Phase III Study of StemEx(R), a Cord Blood Stem Cell Product, for Leukemia and Lymphoma

  7/12/2011

• The Gamida Cell Ltd.-Teva Pharmaceutical Industries Limited Joint Venture Receives FDA Fast Track Designation for StemEx(R) for Leukemia and Lymphoma

  6/21/2010

• Gamida Cell Ltd.: Data Monitoring Committee Recommends Continuation of Phase III Study of StemEx(R), a Cord Blood Stem Cell Product, for Leukemia and Lymphoma

  2/10/2010

• Gamida Cell Ltd.: European Medicines Evaluation Agency Waives Requirement to Test StemEx(R) in Paediatric Patients 17 Years of Age and Under

  1/19/2010

• Gamida Cell Ltd. Announces Feasibility Study With Weill Cornell Medical College

  12/2/2009

• StemEx Noted as a Reliable Investigational Product of an Expanded Population of Stem Cells at Umbilical Cord Blood Symposium in Israel

  11/2/2009

• Gamida Cell Ltd. and Cellerix Partner on Feasibility Study Pre-clinical Study Will Test new Method of Improving Clinical Efficacy of Expanded Populations of Adult Stem Cells Obtained From Adipose Tissue

  10/21/2009

• Gamida Cell Ltd. Release: Article Published in Expert Opinion on Biological Therapy Evaluates StemEx(R) (carlecortemcel-l) for Leukemia and Lymphoma

  10/19/2009

• Gamida Cell Ltd.: Article Published in Expert Opinion on Biological Therapy Evaluates StemEx(R) (carlecortemcel-l) for Leukemia and Lymphoma

  9/30/2009

• Gamida Cell Ltd. Release: StemEx(R), a Gamida Cell-TEVA Joint Venture Cell Therapy Product, Receives Orphan Medicinal Product Designation in the European Union

  3/11/2009

• Gamida Cell Ltd. Announces License Agreement with Amgen (JOBS) to Support Development and Commercialization of StemEx(R) for Hematological Malignancies

  7/21/2008

• Gamida Cell Ltd. Signs Collaboration Agreement With Biologics Delivery Systems Group

  7/14/2008

• NovaThera and Gamida Cell Ltd. Announce a Collaboration Agreement to Develop Cell Therapeutics for Lung Disease

  5/9/2007